Navigation Links
Varian Medical Systems Schedules First Quarter FY2009 News Release and Conference Call
Date:12/10/2008

PALO ALTO, Calif., Dec. 10 /PRNewswire-FirstCall/ -- Varian Medical Systems (NYSE: VAR) announced today that it will report results for first quarter of fiscal year 2009 following the close of regular trading on Thursday, January 29, 2009. The news release will be followed by a teleconference available to all interested parties at 2:00 p.m. PT.

The Varian Medical Systems quarterly results can be accessed on January 29, 2009. The news release and information on the conference call webcast will be available on the company website at: www.varian.com/investor. Details on the conference call and replay follow:

    Teleconference:   Telephone from within the U.S.:
                      -- Dial 1-866-271-0675 and enter access code
                         46529406 prior to the call at
                         2:00 p.m. PT/5:00 p.m. ET.
                         Telephone from outside the U.S.:
                      -- Dial 1-617-213-8892 and enter access code
                         46529406 prior to the call at
                         2:00 p.m. PT/5:00 p.m. ET.
                      *Note: If the number of lines allocated to the
                      call is exhausted, the webcast or replay should be
                      utilized.

    Replay:           The teleconference will be rebroadcast until
                      8:00 p.m. ET, Friday, January 30, 2009 and can be
                      accessed by phone or Web link as follows:
                      -- Telephone from within the U.S.: Dial
                         1-888-286-8010 and enter access code 54317886.
                      -- Telephone from outside the U.S.: Dial
                         1-617-801-6888 and enter access code 54317886.
                      -- Internet: Click on the "Quarterly Conference Call"
                         icon on the company's investor relations website
                         at www.varian.com/investor
                      -- Web conferences will be archived on the company
                         website for a year.

For automatic "e-mail alerts" regarding Varian news and events investors can subscribe on the company website: http://varian.investorroom.com/index.php?s=58.

For additional information contact Anne Rambo at 650-424-5834 or anne.rambo@varian.com.

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 4,800 people who are located at manufacturing sites in North America and Europe and in its 60 sales and support offices around the world. For more information, visit http://www.varian.com/.

    FOR INFORMATION CONTACT:
    Spencer Sias, (650) 424-5782
    Vice President, Corporate Communications
    and Investor Relations
    spencer.sias@varian.com


'/>"/>
SOURCE Varian Medical Systems
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. NEW Line of Pushbutton Pill Cases Launched by Variant Products
2. Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto
3. Few Ontario women with invasive ovarian cancer referred for genetic testing of breast cancer genes
4. International study supports new standard of treatment for women with advanced ovarian cancer
5. Study unmasks how ovarian tumors evade immune system
6. Varian Medical Systems to Exhibit the Latest X-Ray Image Detectors, X-Ray Tubes, and Cancer Treatment Technologies at RSNA This Year
7. Ortho Biotech Announces NDA Submission for Trabectedin for the Treatment of Relapsed Ovarian Cancer
8. New platinum-phosphate compounds kill ovarian cancer cells
9. Protein compels ovarian cancer cells to cannibalize themselves
10. Top Indian Cancer Hospital to Introduce Advanced Radiosurgery Treatments With Novalis Tx from Varian Medical Systems and BrainLAB
11. Varian Medical Systems Schedules Fiscal Year End Review in New York
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... (PRWEB) , ... August 23, 2017 , ... ... of the American Academy of Orthopaedic Surgeons , points out that therapeutic ... suffering from pain or injury. According to the report, a wider scope of ...
(Date:8/22/2017)... ... 22, 2017 , ... The old adage “you are what ... eating healthy foods. But this well-known piece of nutrition advice ignores that an ... carbohydrates—depends not only on properties of the food but also on properties of ...
(Date:8/22/2017)... del Rey, CA (PRWEB) , ... August 22, ... ... of revenue cycle management (RCM) solutions, announced recently the availability of a new ... HIM community in appreciation for their service to the healthcare industry. E/M coding ...
(Date:8/22/2017)... ... ... “Wilderness Voices”: a collection of poetry inspired by life on a Kentucky ... published author, Martha McKown, an ordained United Methodist minister with graduate degrees in Religious ... her older sisters studied High School literature. She loved the early English folk ...
(Date:8/22/2017)... ... August 22, 2017 , ... ... is the Founder and Managing Member for t4 Leadership Development & Consulting. He ... to his definition of “success”: physician leadership development, servant leadership, data driven process ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... Inc. announced today that its fully owned USA ... York City Office in Yonkers, New York ... (TWO 2 ) homecare therapy. This new East Coast location has ... under the company,s DMEPOS accreditation for Home/Durable Medical Equipment Services. ... Advanced Oxygen Therapy Inc. New ...
(Date:8/11/2017)... 11, 2017 DarioHealth Corp. (NASDAQ: DRIO), a ... big data solutions, today announced that it will release ... and host a conference call at 9:00am ET. The ... financial results and its strategy and outlook for the ... Erez Raphael , Chief Executive Officer, and ...
(Date:8/8/2017)... Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a ... reports its financial results for the second quarter ended ... the second quarter 2017 and to date: ... development programs for the Company,s lead project, BL-8040: ... study with BL-8040 as novel stem cell mobilization treatment ...
Breaking Medicine Technology: